Pediatric hematology and oncology
Prospective Evaluation of KIT Mutations and Long-Term Outcomes in Pediatric Core Binding Factor Acute Myeloid Leukemia: A Single Institutional Study in China.
Bei Hou, Feifei Yang, Ruidong Zhang, Maoquan Qin, Jun Li, Ying Wang, Hui Chen, Jing Li, Peijing Qi, Chenguang Jia, Huyong Zheng, Chao Gao
Published: 202510.1080/08880018.2025.2601128
Abstract
The overall incidence of core binding factor acute myeloid leukemia (CBF-AML) in pediatric patients has been reported to be 19%-44.3%. However, the prognostic role of KIT mutations in pediatric CBF-AML remains controversial. This study aimed to inves…
Preview only. Read the full abstract at the source